Carlsbad, CA (August 26, 2010) – SynergEyes®, Inc., the manufacturer of hybrid contact lens technology, announced today that the Food and Drug Administration (FDA) has approved the company’s application for a next generation silicone hydrogel hybrid contact lens.
The new hybrid platform is cleared for use in the correction of hyperopic, myopic and astigmatic refractive error including presbyopia, in aphakic and non-aphakic non-diseased eyes. The lenses are indicated for daily wear for the correction of up to +20.00 and -20.00D in eyes with astigmatism up to +6.00D.
SynergEyes will market the new hybrid technology as two contact lens products: Duette™ hybrid contact lenses for astigmatism and Duette™ Multifocal for presbyopia.
The Duette™ hybrid contact lens products feature a new SynergEyes-developed RGP material, MaxVu™ and a proprietary Flex2O™ silicone hydrogel skirt.
“The high modulus MaxVu™ RGP has a Dk of 130 and class II UV blocker incorporated, while the high DK, low modulus silicone hydrogel skirt has a Dk of 84 and is 32% water. A patent-pending surface treatment, HealthyEyes™, increases wettability and resists protein deposits to maximize comfort,” says Dr. Ramazan Benrashid, Vice President of Research and Development.
“Duette™ hybrid contact lenses represent a significant advancement in the contact lens industry and give eye care professionals an innovative product that delivers an unprecedented combination of visual acuity and comfort to a broad range of patients,” said Jim Ham, CEO for SynergEyes, Inc. “Our next generation products will re-define state-of-the art in the vision correction industry.”
Duette™ hybrid contact lenses for astigmatism are currently available in limited release in select practices in the U.S. A nationwide launch is planned for early 2011. In addition, Duette™ Multifocal will be available in limited release in early 2011.
About SynergEyes
SynergEyes is the leader in hybrid contact lens technology, combining a rigid gas permeable center and a soft outer skirt. The result is a durable “hybrid” lens for patients seeking crisp, clear vision and the all-day comfort of a soft lens. SynergEyes lenses with FDA market-clearance include Duette™ and SynergEyes® A for naturally occurring ametropia, targeting patients with astigmatism, current soft toric lens wearers, and patients demanding optimized vision; ClearKone® and SynergEyes® KC for keratoconus, Duette™ Multifocal and SynergEyes® Multifocal for presbyopia and SynergEyes® PS for post-surgery and post-trauma refractive errors.
Contact
Christina Kirby
Director of Marketing
ckirby@synergeyes.com
619.922.5376
